The U.S. Food and Drug Administration has granted Breakthrough Device designation to MeMed BV Flex, a blood test that differentiates between bacterial and viral infections.
In the rapidly evolving landscape of global medical rehabilitation, the demand for high-quality assistive devices has shifted from basic functionality to rigorous clinical safety and technical ...
RESEDA, CA - March 20, 2026 - PRESSADVANTAGE - Moment of Clarity has released a detailed educational resource outlining ...
Pharmaceutical Technology on MSN
Novo Nordisk’s Wegovy HD secures FDA greenlight amid patent expiries
Wegovy HD’s approval came on the cusp of the drug’s patent expiry in India and China, which leaves it vulnerable to biosimilar competition in these regions.
The products were removed following complaints describing “a gel-like mass and black particles” in the medicine, the FDA said.
With the approval of Wegovy HD, Novo Nordisk joins Johnson & Johnson, Boehringer Ingelheim and USAntibiotics as beneficiaries ...
Javascript must be enabled to use this site. Please enable Javascript in your browser and try again. A Passion for Issues that Matter to Americans 50-Plus is All You ...
A protein already targeted by FDA-approved cancer drugs may also help the body fight influenza, according to new research ...
FDA approves Wellcovorin for ultra-rare disease. The Trump admin touted it as a treatment for autism
The Food and Drug Administration (FDA) on Tuesday granted expanded approval to Wellcovorin for the ultra-rare disease cerebral folate deficiency (CFD) in both children and adults, the same ...
Dr. Vinay Prasad, the head of the Trump administration’s vaccine program, is leaving the FDA next month after a controversial year at the agency where he faced criticism over the FDA’s delay or ...
Dr. Vinay Prasad, a polarizing figure at the Food and Drug Administration who oversaw vaccines, is leaving the agency at the end of April, according to a Health and Human Services spokesperson. As the ...
The Food and Drug Administration’s vaccine chief, Dr. Vinay Prasad, will depart the agency next month, an FDA spokesperson said Friday. Prasad was appointed last year as director of the FDA’s Center ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results